PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Indapamide
Presentation Product Chemical substance Chapter Items dispensed
Indapamide 2.5mg tablets
0202010P0AAAAAA
Indapamide Indapamide Cardiovascular System 770,130
Indapamide 1.5mg modified-release tablets
0202010P0AAADAD
Indapamide Indapamide Cardiovascular System 287,539
Natrilix SR 1.5mg tablets
0202010P0BBABAD
Natrilix Indapamide Cardiovascular System 2,437
Natrilix 2.5mg tablets
0202010P0BBAAAA
Natrilix Indapamide Cardiovascular System 1,566
Cardide SR 1.5mg tablets
0202010P0BMAAAD
Cardide SR Indapamide Cardiovascular System 408
Lorvacs XL 1.5mg tablets
0202010P0BQAAAD
Lorvacs XL Indapamide Cardiovascular System 157
Indipam XL 1.5mg tablets
0202010P0BJAAAD
Indipam XL Indapamide Cardiovascular System 77
Indapamide 2.5mg/5ml oral suspension
0202010P0AAABAB
Indapamide Indapamide Cardiovascular System 51
Alkapamid XL 1.5mg tablets (HBS Healthcare)
0202010P0BNAAAD
Alkapamid XL (HBS Healthcare Ltd) Indapamide Cardiovascular System 36
Rawel XL 1.5mg tablets
0202010P0BLAAAD
Rawel XL Indapamide Cardiovascular System 15
Tensaid XL 1.5mg tablets
0202010P0BHAAAD
Tensaid XL Indapamide Cardiovascular System 2
Alkapamid XL 1.5mg tablets (Rivopharm)
0202010P0BPAAAD
Alkapamid XL (Rivopharm (UK) Ltd) Indapamide Cardiovascular System No data available
Ethibide XL 1.5mg tablets
0202010P0BGAAAD
Ethibide XL Indapamide Cardiovascular System No data available
Mapemid XL 1.5mg tablets
0202010P0BKAAAD
Mapemid Indapamide Cardiovascular System No data available
Nindaxa 2.5 tablets
0202010P0BDAAAA
Nindaxa 2.5 Indapamide Cardiovascular System No data available
Varbim XL 1.5mg tablets
0202010P0BIAAAD
Varbim XL Indapamide Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.